Palestine names conditions for peace treaty with Israel — AbbasWorld March 29, 13:45
Ukraine to continue upholding its position on Russia’s $3bln debt lawsuit in London courtBusiness & Economy March 29, 13:35
Church spokesman slams St. Isaac’s handover referendum bid as ‘counter-productive’Society & Culture March 29, 13:29
Press review: Sberbank's loss on Ukrainian subsidiary sale and Central bank under firePress Review March 29, 13:00
London High Court to hear Russia’s lawsuit on Ukraine’s $3bln debt in expedited procedureBusiness & Economy March 29, 12:31
Putin beefs up number of troops in military to nearly 2 mlnMilitary & Defense March 29, 12:12
China ready to play major role in developing Arctic — vice PMBusiness & Economy March 29, 12:09
Russian deputy PM says Arctic should become eco-friendly regionBusiness & Economy March 29, 11:59
More than 500 militants in Syria’s Homs return to civilian lifeWorld March 29, 11:49
“At the virology center of the Defense Ministry’s Microbiology Research Institute in Sergiyev Posad (Moscow region) and at the Vektor Center for Virology and Biotechnologies in Novosibirsk, vaccines are ready," Valery Chereshnev, chairman of the State Duma’s parliamentary committee on science and technologies and member of the Skolkovo Innovation Center Scientific Council said Monday.
Hopes in the fight against Ebola also lay in Triazaverine, a medicine developed by scientists at the Urals branch of the Academy of Sciences jointly with specialists of the Health Ministry’s Institute for Influenza Studies and the Urals University. Ministry officials have approved the medicine's use, Chereshnev said .“The medicine’s authors have not checked its effect against Ebola but against various lines of flu viruses it has proved to work very actively: great medicine it is,” he added.
“Triazaverine has not been tested against the Ebola virus as the disease was registered only rarely in the past,” one of the medicine's formulators, Academician Oleg Chupakhin, told TASS. Triazaverine had generated good results against 15 forms of flu, including A/H1N1 (swine flu) and H5N1 (avian flu) at any stage of the disease, he said.
Academician Chereshnev said current measures to protect Russia from Ebola are sufficient.
“All people with symptoms of acute respiratory infection are stopped at airports and undergo blood tests," he said. "It is quite realistic to have a final diagnosis within several days. Checking people at airports is effective and the practice is used globally.
Russian Healthcare Minister Veronika Skrovtsova said on Monday that six months will be needed to prepare Russian Ebola vaccine for clinical trials.